AEON Biopharma, Inc. Earnings Per Share Diluted

Quick Answer

AEON Biopharma, Inc. reported Earnings Per Share Diluted of $3.95 (loss) per share for the year ending 2025.

  • AEON Biopharma, Inc. showed a decrease of -105.4% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from AEON Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2022 to 2025), AEON Biopharma, Inc.'s Earnings Per Share Diluted has declined by 939.5%.
  • Historical annual values: Fiscal year 2025: $3.95 (loss) per share | Fiscal year 2024: $72.93 per share | Fiscal year 2022: $0.38 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: